Newsroom
“AI and ML models... can significantly improve the efficacy of drug discovery.”
Arnab Chatterjee, Ph.D
Calibr at Scripps Research
“We are very pleased with the demonstrated potent antiviral activity of MDL-001.”
Davey Smith, MDUC
San Diego Health
“We are very excited to partner with Model Medicines on this important endeavor to identify novel therapeutics to treat the immediate threat of SARS-CoV-2 today and prepare for the pandemics of tomorrow.”
Sumit Chanda, Ph.D.
Sanford Burnham Prebys
“...a game-changer in the global fight against COVID-19.”
Adolfo Garcia-Sastre, Ph.D
Icahn School of Medicine at Mount Sinai